| TONIX PHARMACEUTICALS |
| USA |
| Gesundheit |
| US8902608392 / A40VM0 |
| TPM0 (Frankfurt) / TNXP (NASDAQ) |
| FRA:TPM0, ETR:TPM0, TPM0:GR, NASDAQ:TNXP |
| - |
| https://www.tonixpharma.c.. |
|
Tonix Pharmaceuticals Holding Corp. is a fully integrated, commercial-stage biopharmaceutical company focused on developing, licensing, and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Its primary emphasis ..
>Volltext.. |
| 164.83 Mio. EUR |
| -11 Mio. EUR |
| 11.18 Mio. EUR |
| -105.61 Mio. EUR |
| -105.82 Mio. EUR |
| -12.17 EUR |
| 1.12 Mio. EUR |
| 177.16 Mio. EUR |
| -88.52 Mio. EUR |
| 6.73 |
| 14.45% |
| 15.94% |
| - |
| - |
| - |
| - |
| TONIX |
| 06.05.26 |
|